User contributions
This user is currently blocked. The latest block log entry is provided below for reference:
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500).
- 10:39, 7 May 2012 (diff | hist) . . (+205) . . Rizzo Lab Research (→EGFR and ErbB family)
- 10:27, 7 May 2012 (diff | hist) . . (+107) . . Rizzo Lab Research (→GP41 and viral membrane fusion inhibitor)
- 10:24, 7 May 2012 (diff | hist) . . (-7) . . Rizzo Lab Research (→GP41 and viral membrane fusion inhibitor)
- 10:22, 7 May 2012 (diff | hist) . . (+9) . . Rizzo Lab Research (→GP41 and viral membrane fusion inhibitor)
- 09:01, 3 May 2012 (diff | hist) . . (-39) . . Rizzo Lab Research
- 08:59, 3 May 2012 (diff | hist) . . (0) . . Rizzo Lab Research (→Docking Testset Development)
- 08:57, 3 May 2012 (diff | hist) . . (0) . . File:Docking Testset research image1.png (uploaded a new version of "File:Docking Testset research image1.png") (top)
- 08:53, 3 May 2012 (diff | hist) . . (0) . . Rizzo Lab Research (→Docking Testset Development)
- 08:43, 3 May 2012 (diff | hist) . . (0) . . N File:Docking Testset research image1.png
- 07:46, 3 May 2012 (diff | hist) . . (0) . . Rizzo Lab Research (→Chemical Sampling Method)
- 07:45, 3 May 2012 (diff | hist) . . (0) . . Rizzo Lab Research (→Chemical Sampling Method)
- 07:45, 3 May 2012 (diff | hist) . . (0) . . N File:Chemical Sampling Method image1.png (top)
- 07:30, 3 May 2012 (diff | hist) . . (+237) . . Rizzo Lab Research (→GP41 and viral membrane fusion inhibitor)
- 05:54, 29 March 2012 (diff | hist) . . (+215) . . Rizzo Lab Research (→Cancer)
- 04:59, 28 March 2012 (diff | hist) . . (+8) . . 2012 RCR GROUP MEETING
- 10:33, 15 March 2012 (diff | hist) . . (-114) . . 2012 RCR GROUP MEETING
- 10:27, 15 March 2012 (diff | hist) . . (+70) . . 2012 RCR GROUP MEETING
- 10:23, 15 March 2012 (diff | hist) . . (+91) . . 2012 RCR GROUP MEETING
- 05:15, 20 February 2012 (diff | hist) . . (+50) . . 2012 RCR GROUP MEETING
- 09:03, 15 February 2012 (diff | hist) . . (+12) . . Rizzo Lab Research (→Docking Testset Development)
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500).